Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-18

Clinical Trial Update: A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

This completed early-phase trial measured cerebrospinal fluid proteins in elderly healthy volunteers and participants with mild cognitive impairment or Alzheime…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy, Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED